A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Autor principal: | Sorno, Rubina Haque |
---|---|
Outros Autores: | Khair, Nishat Zareen |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2024
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/23842 |
Registos relacionados
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Por: Khan, Muidul Hasan
Publicado em: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
Por: Ruhee, Noshin Nawer
Publicado em: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
Por: Raju, Md. Ismail
Publicado em: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Por: Ratu, Tabassum
Publicado em: (2024)